You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in the Netherlands

Oct 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Netherlands with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Netherlands, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Netherlands for free:

The Consumer Health in Netherlands market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Netherlands?
  • What are the major brands in Netherlands?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Positive performance in 2010

Consumer health performed well in 2010, driven by renewed efforts from manufacturers to encourage consumers to buy more expensive and value-added products. Manufacturers worked together with retailers in order to improve product display, and also coordinated the introduction of new extensions, supporting them with extensive communication aimed at stimulating curiosity and triggering demand.

Child-specific products drive growth

Child-specific consumer health emerged as one of the best performing categories in 2010, registering current value growth of 6%. More than ever, manufacturers shifted marketing attention towards products which targeted age and gender. Within vitamins and dietary supplements, manufacturers also stimulated demand for multivitamins aimed at older people or pregnant women, or dietary supplements such as fish oils or glucosamine, which help to prevent health problems.

Innovation key to stimulating demand

Despite the low level of switch activity, manufacturers within consumer health are aware that innovation, including the release of brand extensions, is key to building value growth. In 2010, companies which registered growth in sales included large companies such as Novartis Consumer Health and Chefaro International. Companies promoted formulas which assured consumers of quicker and more effective action to treat symptoms, such as Losecosan from Bayer, a more effective antacid formula, or products which enhanced the notion of prevention; this being highly effective in terms of attracting Dutch consumers.

Internet retailing grows rapidly, capturing a higher distribution share

Drugstores/parapharmacies, the largest channel in consumer health, is witnessing strong competition from grocery retailers and non-store retailing. Internet retailing in particular is gaining more followers in the Netherlands, as it is valued as a channel for convenience and as quick source of product information and price comparison. All categories within consumer health saw rapid growth in internet retailing in 2010, whilst grocery retailers also expanded their sales area for these products.

Future value growth driven by products which focus on prevention and convenience

Consumer health is expected to see positive growth over the forecast period. However, the need to pursue innovation and steady investment in order to build growth will create more pressure for manufacturers. Companies are committed to further investing in consumer health, with products which emphasise key demand triggers such as prevention, convenience and vitality.

Table of Contents

Table of Contents

Consumer Health in the Netherlands - Industry Overview

EXECUTIVE SUMMARY

Positive performance in 2010

Child-specific products drive growth

Innovation key to stimulating demand

Internet retailing grows rapidly, capturing a higher distribution share

Future value growth driven by products which focus on prevention and convenience

KEY TRENDS AND DEVELOPMENTS

Gradual recuperation of the Dutch economy in 2010

Internet retailing drives overall growth within Dutch retailing in 2010

The ageing population impacts the Dutch demographic structure

Herbal-based products enhance sense of security amongst Dutch consumers

Homeopathic products pose strong competition to consumer health

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Penetration of Private Label by Category 2005-2010
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

  • Summary 2 Research Sources

Consumer Health in the Netherlands - Company Profiles

Chefaro International BV in Consumer Health (Netherlands)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Chefaro International BV: Competitive Position 2010

Koninklijke Uthermöhlen BV in Consumer Health (Netherlands)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 6 Koninklijke Uthermöhlen NV: Competitive Position 2010

Novum Pharma BV in Consumer Health (Netherlands)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Novum Pharma BV: Competitive Position 2010

Adult Mouth Care in the Netherlands - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care saw a slightly improved performance in 2010. This remains an inactive category, characterised by a low level of promotion and new product development.

SWITCHES

COMPETITIVE LANDSCAPE

  • The category is highly concentrated amongst a few long-established brands. Corsodyl led in 2010 with a 46% value share, followed by Pyralvex with a 36% share.

PROSPECTS

  • Adult mouth care is expected to register positive but slow growth over the forecast period (3%). There is the intention of developing smaller categories such as this in the Netherlands, but investment in new product development and advertising are needed to educate consumers. Few consumers purchase these products on their own initiative, and a change of attitude is required through investment in advertising.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2005-2010
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 14 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 15 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in the Netherlands - Category Analysis

HEADLINES

TRENDS

  • In 2010 analgesics saw sales driven by a general consumer desire to acquire products which were more effective in treating the common symptoms of pain. Larger categories such as acetaminophen continued to lead, but more Dutch people also chose to switch to ibuprofen and smaller categories in analgesics, such as naproxen and diclofenac.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer Consumer Care was the largest manufacturer and distributor of analgesics in the Netherlands in 2010, accounting for a 23% value share. Bayer owns key top-selling brands including Saridon, Sarixell and Finimal.

PROSPECTS

  • The market for Dutch analgesics is considered mature in larger categories such as acetaminophen. However, manufacturers’ and retailers’ attention will focus on further developing smaller categories in analgesics during the forecast period. Dutch consumers are aware of the attributes of analgesics, and do not necessarily seek the advice of a doctor before purchasing them, meaning that a more open attitude will benefit demand, resulting in 7% growth in constant value terms.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2005-2010
  • Table 19 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 21 Analgesics Company Shares by Value 2006-2010
  • Table 22 Analgesics Brand Shares by Value 2007-2010
  • Table 23 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in the Netherlands - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping products generated healthy sales in 2010, increasing by 6% in current value terms. Consumer demand continues to rise for a solution to these common problems.

SWITCHES

COMPETITIVE LANDSCAPE

  • The fact that most of the products sold are herbal-based gives confidence to Dutch consumers. The leading brands in calming and sleeping products are of Dutch origin with a long-established presence, such as Nachtrust and Valdispert. Vemedia was the leading manufacturer with a 58% value share in 2010, with its brands Valdispert and Melatomatine.

PROSPECTS

  • Calming and sleeping products is expected to generate strong growth over the forecast period (19% in constant value terms). Manufacturers will look to increase the consumer base, investing in new formulas which have proven to be more effective in treating sleeping problems.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2005-2010
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 27 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 28 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy (hay fever) remedies performed well in 2010, driven by intense promotion of more expensive products, and a firm commitment by Dutch consumers to prevent or more quickly reduce the symptoms of congestion and colds.

SWITCHES

COMPETITIVE LANDSCAPE

  • The leading two brands within cough, cold and allergy (hay fever) remedies in 2010 were the medicated confectionery brands Fisherman’s Friend (Lofthouse of Fleetwood) and Vicks (Richardson-Vicks). Together, these two brands held a 23% share of overall value sales, reflecting the importance of medicated confectionery within the category. Medicated confectionery is readily available, and is sometimes purchased as an alternative to sugar confectionery, rather than purely for its medicinal qualities.

PROSPECTS

  • Cough, cold and allergy (hay fever) remedies in the Netherlands is expected to show positive growth in the forecast period (2% CAGR), driven by the introduction of new extensions which have proven to be more effective and convenient for consumers to treat the symptoms of colds, flu and allergies. Dutch consumers have shown that they are open to spending more money on formulas which assure a quicker solution, meaning that manufacturers will continue to develop the category, encouraging a shift towards more expensive products.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 33 Sales of Decongestants by Category: Value 2005-2010
  • Table 34 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 36 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in the Netherlands - Category Analysis

HEADLINES

TRENDS

  • Digestive remedies recorded sustained growth in 2010, benefiting from intensified promotion and a focus by the leading manufacturers on new products. Whilst digestive remedies is still small in comparison with other consumer health categories, the Dutch are being more exposed to OTC products, becoming more informed and willing to purchase formulas which offer added-value.

SWITCHES

COMPETITIVE LANDSCAPE

  • Solvay led digestive remedies with a 9% value share in 2010, with a 6% share for the Norit brand and 3% for Duphalac. The company’s share increased thanks to growth in sales for Norit, in line with good sales of diarrhoeal remedies overall. The leading brand was Diacure from Taxandria Pharmaceutica, which held an 8% share of overall value sales and a 37% share of diarrhoeal remedies.

PROSPECTS

  • Digestive remedies is expected to register impressive growth over the forecast period (12%). Considering that it is still one of the smallest categories within OTC products, it is seen as having more potential for expansion. Manufacturers are committed to continue investing, with the possible introduction of more extensions focused on convenience and rapid relief.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 43 Digestive Remedies Company Shares by Value 2006-2010
  • Table 44 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in the Netherlands - Category Analysis

HEADLINES

TRENDS

  • Ear care is one of the smallest categories within consumer health. Sales experienced healthy growth in 2010, boosted by the wider distribution of existing products, but penetration remained low, as consumers were not yet in the habit of purchasing such products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Otalgan is the largest brand within ear care, accounting for a 72% value share in 2010. The manufacturer, Vemedia consolidated its leading position with renewed advertising for Otalgan in 2009, and the introduction of a spray format. The advertising behind Otalgan focused on educating consumers on the need for good ear care, and on how the formula helps to ensure hygiene and overall ear care.

PROSPECTS

  • OTC ear care is expected to register positive growth (16%) during the forecast period. Manufacturers and retailers are expected to invest more, with the introduction of adapted packaging, formulas and formats, including sprays.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2005-2010
  • Table 48 Sales of Ear Care: % Value Growth 2005-2010
  • Table 49 Ear Care Company Shares by Value 2006-2010
  • Table 50 Ear Care Brand Shares by Value 2007-2010
  • Table 51 Forecast Sales of Ear Care: Value 2010-2015
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in the Netherlands - Category Analysis

HEADLINES

TRENDS

  • Whilst there were high expectations for growth since the switch of these products in 2006, sales maintained stable growth. Emergency contraception does not receive high support in terms of advertising or new product development. In addition, OTC products are impacted by competition from prescription-based medicines such as Mifegyne.

COMPETITIVE LANDSCAPE

  • NorLevo remained the only brand of emergency contraception within consumer health in 2010. Due to the fact that the category is small, and the product requires advice before its purchase, many parapharmacies/drugstores choose not to place it in their range or on open shelves. Consumers are also able to obtain reimbursement, meaning that a large proportion of sales are under prescription.

PROSPECTS

  • Emergency contraception is expected to show positive growth over the forecast period, increasing by 23% in constant value terms. Manufacturers foresee no specific drivers of sales in the category in the short to medium term, or potential switches. Prescription-based products will remain the first choice, as professional advice will remain important before deciding to purchase such products.

CATEGORY DATA

  • Table 53 Sales of Emergency Contraception: Value 2005-2010
  • Table 54 Sales of Emergency Contraception: % Value Growth 2005-2010
  • Table 55 Emergency Contraception Company Shares by Value 2006-2010
  • Table 56 Emergency Contraception Brand Shares by Value 2007-2010
  • Table 57 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 58 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in the Netherlands - Category Analysis

HEADLINES

TRENDS

  • Eye care remained a marginal category within the Dutch consumer health market in 2010. Whilst sales showed positive growth, the category was not stimulated in terms of promotion or new product development. A main reason cited is that consumers do not usually buy such products on their own, seeking medical recommendation based on safety grounds.

SWITCHES

COMPETITIVE LANDSCAPE

  • Optrex remained the largest brand sold in Dutch parapharmacies/drugstores and chemists/pharmacies in 2010, claiming nearly two thirds of value sales. After intense promotion in 2009 the brand maintained its share, but received lower support. Optrex has a wide distribution reach; it is present in more than 90% of all drugstores.

PROSPECTS

  • Eye care is poised to generate healthy growth over the forecast period (7%). Still increasing from a low base, much growth will depend on the commitment by manufacturers to stimulate demand with renewed promotion. Given the fact that OTC eye care is small, retailers will look at opportunities together with manufacturers to develop more sales and boost penetration. Factors such as high exposure to television and computer screens offer more opportunities for the development of eye care products to prevent irritation, for example.

CATEGORY DATA

  • Table 59 Sales of Eye Care by Category: Value 2005-2010
  • Table 60 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 61 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 62 Eye Care Company Shares by Value 2006-2010
  • Table 63 Eye Care Brand Shares by Value 2007-2010
  • Table 64 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 65 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in the Netherlands - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products saw a positive performance in 2010, continuing the trend from the previous year. Manufacturers placed the emphasis on issues such as prevention in 2010, contributing to generating steady demand for herbal/traditional products, which helped to increase general health levels and avoid disease.

COMPETITIVE LANDSCAPE

  • Herbal/traditional products shows varying degrees of concentration. Manufacturers with a larger presence in categories in which herbal products dominate, such as calming and sleeping products and vitamins and dietary supplements, have the highest sales.

PROSPECTS

  • Herbal/traditional products is expected to generate 15% growth in constant value terms over the forecast period, driven by continued stimulation of demand for products incorporating natural ingredients. Dutch consumers have traditionally favoured natural products, but this desire is greater than ever, with consumers willing to pay a price premium in comparison with standard products, provided the natural ingredients are more gentle and do not cause unwanted effects.

CATEGORY DATA

  • Table 66 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 67 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 68 Herbal/Traditional Products Company Shares 2006-2010
  • Table 69 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 70 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 71 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in the Netherlands - Category Analysis

HEADLINES

TRENDS

  • According to a main manufacturer, relatively low activity in terms of switches, coupled with the fact that Dutch consumers tend to seek professional advice for skin care, explains the small size of medicated skin care.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer Consumer Care was the largest manufacturer within medicated skin care in the Netherlands in 2010, accounting for a 13% value share. Bayer led thanks to its top-selling antifungal brand Canesten, a product which continued to receive marketing support in 2010 through the promotion of more convenient formats, such as formulas which are easier to apply and absorb more quickly. Canesten gained increased distribution in grocery retailers, with a higher presence in supermarkets, in addition to parapharmacies/drugstores and chemists/pharmacies, its main channels.

PROSPECTS

  • Medicated skin care is forecast to grow by a CAGR of 2% over the next five years. From a small base, medicated skin care has better development prospects than more mature consumer health categories, such as analgesics. Manufacturers will continue to work to promote products in order to increase usage and attract new consumers, whilst investing in communication to increase awareness of OTC products, instead of necessarily resorting to a medical professional for Rx medicines.

CATEGORY DATA

  • Table 72 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 73 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 74 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 75 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 76 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 77 Acne Treatments Brand Shares by Value 2007-2010
  • Table 78 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 79 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 80 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in the Netherlands - Category Analysis

HEADLINES

TRENDS

  • NRT smoking cessation aids registered a positive performance in 2010, with sales experiencing healthy growth, fuelled by a general consumer willingness to follow healthier lifestyles. High-profile public campaigns appear to have had an impact in the Netherlands, as the total number of smokers showed a decrease when compared with the beginning of the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • NRT smoking cessation aids was largely concentrated between four key players in 2010. Novartis Consumer Health led with a 53% value share, derived from its brand Nicotinell.

PROSPECTS

  • The total number of smokers is poised to continue decreasing in the Netherlands, aided by a general will amongst the population to pursue healthier lifestyles. Whilst this represents an opportunity for NRT smoking cessation aids, manufacturers foresee more challenges in developing sales, given the fact that investment is needed to educate consumers on the effectiveness of these products.

CATEGORY INDICATORS

  • Table 81 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 82 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 83 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 84 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 85 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 86 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 87 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 88 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in the Netherlands - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition continued to stimulate strong interest amongst Dutch consumers active in fitness activities. Sales continued to generate very positive growth, driven by intense promotion of these products and manufacturers being able to reach new consumers.

COMPETITIVE LANDSCAPE

  • Sports nutrition is fairly fragmented, with several brands being present, but few achieving overall distribution. Larger brands have a longer-established presence in healthfood stores and grocery retailers, with smaller ones witnessing a sudden rise in share, driven by specific promotions. In 2010 sports nutrition witnessed more promotional support for mainstream brands, with manufacturers committed to building brand awareness and increasing sales.

PROSPECTS

  • Sports nutrition is forecast to emerge as one of the best performing categories within the Dutch consumer health market, with sales rising by 26% in constant value terms. It is still considered fairly underdeveloped, and manufacturers see positive prospects for growth, derived from the expansion of the consumer base. Interest in healthy living and fitness is growing rapidly amongst Dutch consumers, thus sports nutrition has further potential for growth, provided education about and knowledge of these products continue to grow.

CATEGORY DATA

  • Summary 9 Sports Nutrition, Category Rankings 2010
  • Table 89 Sales of Sports Nutrition: Value 2005-2010
  • Table 90 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 91 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 92 Sports Nutrition Company Shares 2006-2010
  • Table 93 Sports Nutrition Brand Shares 2007-2010
  • Table 94 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 95 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in the Netherlands - Category Analysis

HEADLINES

TRENDS

  • Sales of vitamins and dietary supplements in 2010 were driven by manufacturers focusing on prevention and segmentation. Child-specific vitamins and dietary supplements continued to generate strong growth, as manufacturers encouraged parents to buy child-specific products. In addition, large and more mature categories, such as multivitamins, witnessed increased segmentation, with products targeted according to age, or towards pregnant women.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Chefaro International was the largest manufacturer within vitamins and dietary supplements in 2010, with a value share of 13%. This was achieved through its brand Davitamon. Davitamon continued to be promoted with specific formulas targeted towards different consumers, such as pregnant women, children, adults and senior citizens. The company introduced on its website the “Vitaminetest”, whereby consumers can fill in data and the programme shows what dietary supplement or vitamin is needed.

PROSPECTS

  • Value sales are expected to rise by 12% in constant value terms over the forecast period. Sales will be driven by dietary supplements which help promote prevention and are lesser-known to the majority of Dutch people. Manufacturers and retailers will promote smaller categories in dietary supplements in order to offer more products to consumers and create more demand. Categories such as guarana and cranberry are still small, but have good prospects for growth during the forecast period.

CATEGORY DATA

  • Summary 10 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 96 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 97 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 98 Dietary Supplements by Positioning 2005-2010
  • Table 99 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 100 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 101 Vitamins Brand Shares by Value 2007-2010
  • Table 102 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 103 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 104 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in the Netherlands - Category Analysis

HEADLINES

TRENDS

  • Weight management generated poor results in 2010, continuing the trend evident during 2009. Despite efforts by manufacturers in terms of new product developments, the consumer base for slimming products is decreasing, impacted by changes in consumers’ eating habits. Slimming products also had relatively bad publicity from organisations such as the Voedingcentrum, a government body which provides advice on healthy eating.

COMPETITIVE LANDSCAPE

  • Herbalife International was the largest company in slimming products in the Netherlands in 2010, with a 36% value share. Intense competition affected the direct selling channel, in which Herbalife is mostly active. Direct selling accounts for the majority of Herbalife’s sales, but its products can also be found through internet retailing at portals such as drogisterij.net. It markets weight loss supplements and meal replacement slimming products in the Netherlands, and provides most advice through its network of re-sellers, complementing this with additional information through its website herbalife.nl

PROSPECTS

  • Sales of weight management products are expected to continue to suffer over the forecast period, dropping as much as 23%. Demand will continue to contract as more people resort to alternatives and more natural ways of losing weight instead. However, the category is expected to stabilise over the forecast period, reaching a more realistic size and still targeting the population interested in purchasing these products.

CATEGORY DATA

  • Table 105 Sales of Weight Management: Value 2005-2010
  • Table 106 Sales of Weight Management: % Value Growth 2005-2010
  • Table 107 Weight Management Company Shares 2006-2010
  • Table 108 Weight Management Brand Shares 2007-2010
  • Table 109 Forecast Sales of Weight Management: Value 2010-2015
  • Table 110 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in the Netherlands - Category Analysis

HEADLINES

TRENDS

  • Wound care registered healthy growth in 2010, considering the maturity of the category in the Netherlands. Manufacturers encouraged consumers to shift to more modern and expensive products, promoting formulas which claim faster relief and cure wounds.

COMPETITIVE LANDSCAPE

  • Beiersdorf was the largest manufacturer within wound care in the Netherlands in 2010, accounting for a 44% value share. Beiersdorf markets top-selling brands Hansaplast and Hansasport, both with a high degree of concentration and a distribution penetration of over 90%.

PROSPECTS

  • Wound care exhibits a high degree of maturity, but despite this, 7% growth is anticipated over the forecast period. Manufacturers are expected to continue pouring resources and investment into new product development in order to build sales. The idea will remain to encourage consumers to switch to more technologically-advanced products which help to cure wounds faster and in a more convenient way.

CATEGORY DATA

  • Table 111 Sales of Wound Care by Category: Value 2005-2010
  • Table 112 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 113 Wound Care Company Shares by Value 2006-2010
  • Table 114 Wound Care Brand Shares by Value 2007-2010
  • Table 115 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 116 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Green Tea Extract
            • Isoflavones
            • Lycopene
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Lecithin
            • Panthetine
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Country Report

Consumer Lifestyle

Future Demographic

Country Report